Ori Biotech in a $100m in Series B funding round led by Novalis LifeSciences

Biotech Health services

Investments

17 January 2022

Ori Biotech (company)

Biotech Health services

Total investments received (USD): 130m

Round value (USD): 100m

Round investors: Amadeus Capital Chimera Investment Delin Ventures Northpond Ventures Octopus Ventures Novalis Biotech Puhua Capital

Industry: Biotech Health services

Biotech Health services Manufacturing

Investments 26 November 2021

Biotech Competitive Intelligence Health services Software Services

Investments 05 November 2021